We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Imaging System with Analysis Software Developed for Accelerated 2D Gel Imaging and Analysis

By Labmedica staff writers
Posted on 28 Feb 2008
A new two-dimensional (2D) gel imaging system has a fully motorized and automated light tight darkroom with high-resolution 8.3-megapixel image capture capability. More...


The fast capture time capability of the BioSpectrum 800, developed by UVP, LLC (Upland, CA, USA), combined with Nonlinear Dynamics' (Newcastle upon Tyne, UK) SameSpots analysis software, is easy to use, and accelerates and simplifies the research lab workflow. The BioSpectrum 800 imaging system accommodates a variety of gel sizes, making it a less costly alternative to the more expensive and slower 2D laser scanner systems currently used today.

"The release of the new BioSpectrum 800 imaging system and the availability of the SameSpots analysis software allows UVP to provide the same world-class product, quality, and service to the 2D electrophoresis market that we have provided the 1D electrophoresis market since 1988,” commented Alexander Waluszko, vice president sales/marketing at UVP.

"SameSpots technology, with the remarkable combination of extreme ease of use and statistical power, is the best 2D analysis software and is the ideal match for our new BioSpectrum 800 imaging system,” according to Sean Gallagher, Ph.D., vice president and CTO of UVP.

Will Dracup, CEO of Nonlinear Dynamics said, "By distributing the BioSpectrum 800 with SameSpots, UVP can now offer their customers the ultimate solution for proteomics research. Together, the BioSpectrum 800 and SameSpots solutions offer huge speed improvements, giving scientists the ability to analyze enough replicates for true statistical power in only a matter of hours. Running enough replicates is key to generating robust and reliable data from your proteomics research--so it is great to be making this more accessible than ever before.”

Leighton Smith, president and CEO of UVP, commented, "The strategic relationship with Nonlinear Dynamics further strengthens UVP's commitment to offer life scientists the best imaging and analysis solutions available in the industry today. The combination of UVP's BioSpectrum 800 Imaging System and SameSpots Analysis Software provides our customers with a complete 2D imaging acquisition and analysis solution.”

UVP designs and manufactures a wide spectrum of instruments and imaging systems for life science applications. As a leading developer and manufacturer of ultraviolet products since 1932, UVP continues to provide products with a specialty in fluorescence and luminescence-based imaging applications in the molecular, cellular, and whole organism life sciences.


Related Links:
UVP
Nonlinear Dynamics

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.